High blood pressure is one of the most common health issues many face in the world today. But with a few lifestyle changes, the risks of suffering from serious conditions as a result of this issue can be lowered, like a few teas.
Express reports that three kinds of herbal teas are known for having properties that can help lower a high blood pressure reading. Herbal teas, or teas in general, are already known for being a healthy option for those who want to lower their risks of developing serious illnesses or those who simply want to stay healthy. Some of the teas that can help lower high blood pressure readings are hibiscus tea, black tea, and oolong tea.
Hibiscus tea has been shown to lower blood pressure in many studies. One study in particular was done over a six-week period, and 65 participants with high blood pressure were given placebo or hibiscus tea. After the study, the researchers found that the participants that drank hibiscus tea had lowered systolic blood pressure - the pressure in the blood vessels when the heart beats - compared to those who only took placebo.
Black tea has also been proven to have properties that can lower blood pressure. This type of tea can improve endothelial cell function or the lining inside the blood vessels. Oolong tea’s blood pressure lowering properties also lower bad cholesterol levels and a lower risk of heart disease.
Tea is not the only drink that has been shown to lower blood pressure readings. Another report reveals that drinks like tomato juice and beetroot juice are shown to lower blood pressure readings. Unsalted tomato juice in particular has been shown to be attributed to lowered blood pressure readings as well as lower levels of bad cholesterol according to a study in Japan.
As for beetroot juice, a study showed that consuming a glass or eight ounces of beetroot juice everyday had lowered blood pressure readings. This is because beetroot also contains nitrate, a compound in the juice that can turn into nitric acid in the blood, relaxing and softening the blood vessels.


Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure 



